ADV462

N/A

Report date: 2022/12/05 14:07:33
NME

Base Information

Drug NameADV462
Drug Alias NameADV-462
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSigma-2 receptor antagonists
TargetsSigma-2 receptor
Therapy Area/IndicationsDown SyndromeAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdvantx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdvantx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDown SyndromeAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A